D. Paździor

Higher CD34(+) and CD3(+) cell doses in the graft promote long-term survival, and have no impact on the incidence of severe acute or chronic graft-versus-host disease after in vivo T cell-depleted unrelated donor hematopoietic stem cell transplantation in children.

Monika Mielcarek, Marek Ussowicz, M. Ussowicz, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.